184 related articles for article (PubMed ID: 9521333)
1. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension.
Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
Circulation; 1998 Mar; 97(9):851-6. PubMed ID: 9521333
[TBL] [Abstract][Full Text] [Related]
2. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
3. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans.
Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
Hypertension; 1997 Oct; 30(4):918-21. PubMed ID: 9336393
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
[TBL] [Abstract][Full Text] [Related]
5. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO
Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.
Panza JA; Casino PR; Kilcoyne CM; Quyyumi AA
Circulation; 1993 May; 87(5):1468-74. PubMed ID: 8491001
[TBL] [Abstract][Full Text] [Related]
7. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
8. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
[TBL] [Abstract][Full Text] [Related]
9. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level.
Panza JA; Casino PR; Kilcoyne CM; Quyyumi AA
J Am Coll Cardiol; 1994 Jun; 23(7):1610-6. PubMed ID: 7515084
[TBL] [Abstract][Full Text] [Related]
10. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
Panza JA; Casino PR; Badar DM; Quyyumi AA
Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
[TBL] [Abstract][Full Text] [Related]
12. Age-related reduction of NO availability and oxidative stress in humans.
Taddei S; Virdis A; Ghiadoni L; Salvetti G; Bernini G; Magagna A; Salvetti A
Hypertension; 2001 Aug; 38(2):274-9. PubMed ID: 11509489
[TBL] [Abstract][Full Text] [Related]
13. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.
Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
Circulation; 1993 Dec; 88(6):2541-7. PubMed ID: 8252665
[TBL] [Abstract][Full Text] [Related]
14. Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients.
Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
J Am Coll Cardiol; 1998 Nov; 32(5):1207-13. PubMed ID: 9809927
[TBL] [Abstract][Full Text] [Related]
15. Selective loss of microvascular endothelial function in human hypercholesterolemia.
Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
17. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
[TBL] [Abstract][Full Text] [Related]
18. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients.
Taddei S; Virdis A; Mattei P; Ghiadoni L; Sudano I; Salvetti A
Circulation; 1996 Sep; 94(6):1298-303. PubMed ID: 8822983
[TBL] [Abstract][Full Text] [Related]
19. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
[TBL] [Abstract][Full Text] [Related]
20. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
Taddei S; Versari D; Cipriano A; Ghiadoni L; Galetta F; Franzoni F; Magagna A; Virdis A; Salvetti A
J Am Coll Cardiol; 2006 Aug; 48(3):508-15. PubMed ID: 16875977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
